Associate Director, Project Management Office (PMO)
What’s in it for you?
We are seeking a talented and passionate individual who thrives in a dynamic, fast-paced, team-oriented, and collaborative environment to be part of our success. In this role, you will be a member of the Program Management team and be responsible for implementing, leading and coordinating the Project Management Office (PMO) area. Reporting to the Vice President – Program Management – Pulmonary, you will apply your expertise and understanding of drug development to establish a structure that standardizes the project/program-related processes and facilitates the sharing of resources, methodologies, tools, and techniques.
What will you be doing?
- Designing and building standardized PMO reporting tools, dashboards, and scoring metrics to facilitate regular communication of portfolio progress to company’s leadership and other internal stakeholders
- Coordinate communication across projects, periodically seeking user feedback and optimizing PM tools, structure and reporting
- PM monthly report
- Program dashboard report
- Program risk registers
- SharePoint site optimization/organization
- PM tools expert and super user/trainer
- Create a development program resource model (e.g. FTEs by function by program stage) and support the tracking and management of resource allocation across the portfolio.
- Develop a process and template for program budget tracking and reporting
- Program risk trackers and framework, and quarterly enterprise risk assessment
- Working with Global Program Leaders and company leadership to design and maintain end-to-end portfolio governance and management practices
- Support program review and portfolio prioritization processes
- Ad hoc projects, such as After-Action Reviews
- PM orientation and training module for on-boarding of new hires
- Provide support to the program management team, coaching on problem solving approaches, methods, tools and techniques
- Develop and execute the global communication plan for the Portfolio Management Office
- Monitor compliance with project management standards, policies, procedures, and templates
- Stay engaged with the industry to track PM best practices and implement as appropriate. Directly lead, design and implement the continuous improvement processes for the PMO business processes, systems, and tools.
- Maintain PM career ladder
What are we looking for?
- Degree in life sciences (MS, MBA preferred), with at least 8 years of relevant professional experience in the biopharmaceutical industry, including at least 3 years in relevant project/program management roles within Project Management Office (PMO) or equivalent
- Project Management Training and/or Project Management Professional (PMP) Certification preferred
- Understanding of applicable Regulatory Agency regulations, guidelines, and/or specifications (e.g., FDA, EMA, ICH, etc)
- Applied knowledge of project management tools and processes
- Strong computer skills; skilled at using Word, Excel, PowerPoint, Microsoft Project and Enterprise Resource Planning (ERP) tools
- Strong written and oral communication skills
- Ability to work collaboratively with others across all functions and levels within the organization
- Excellent organizational skills and comfort with multi-tasking in a fast-paced environment
How will you grow with us?
You will be joining a growing and advancing company with an active pipeline and will help drive the pulmonary therapeutic area by collaborating with passionate team members. As a part of a dynamic team, you will have the ability to influence company`s portfolio, build ownership in your role and seek new opportunities for growth. If you are looking to be a part of an innovative and fast-paced environment, join our team!
*In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and complete the required employment eligibility verification document form upon hire.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron’s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair. Acceleron focuses its research, development, and commercialization efforts in pulmonary and hematologic diseases. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension (PAH), having reported positive topline results of the PULSAR Phase 2 trial. The Company is currently planning multiple Phase 3 trials with the potential to support its long-term vision of establishing sotatercept as a backbone therapy for patients with PAH at all stages of the disease. Acceleron is also investigating the potential of its early-stage pulmonary candidate, ACE-1334, which it plans to advance into a Phase 1b/2 trial in systemic sclerosis-associated interstitial lung disease (SSc-ILD) next year. In hematology, REBLOZYL® (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States, Europe, and Canada for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis. For more information, please visit www.acceleronpharma.com. Follow Acceleron on Social Media: @AcceleronPharma and LinkedIn.